Mark E. Dmytruk is Officer of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 31,610 shares of DNA, which is worth approximately $208,309. The most recent transaction as insider was on Dec 02, 2022, when has been sold 30,102 shares (Class A Common Stock) at a price of $1.94 per share, resulting in proceeds of $58,397. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.6K
97.1% 3M change
95.02% 12M change
Total Value Held $208,309

Mark E. Dmytruk Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2022
SELL
Open market or private sale
$58,397 $1.94 p/Share
30,102 Reduced 6.68%
420,555 Class A Common Stock
Dec 01 2022
BUY
Exercise of conversion of derivative security
-
66,583 Added 12.87%
450,657 Class A Common Stock
Nov 03 2022
SELL
Open market or private sale
$80,794 $2.64 p/Share
30,604 Reduced 7.38%
384,074 Class A Common Stock
Nov 01 2022
BUY
Exercise of conversion of derivative security
-
66,589 Added 13.84%
414,678 Class A Common Stock
Oct 06 2022
SELL
Open market or private sale
$907,579 $3.25 p/Share
279,255 Reduced 44.51%
348,089 Class A Common Stock
Oct 05 2022
BUY
Exercise of conversion of derivative security
-
618,242 Added 49.63%
627,344 Class A Common Stock
Oct 03 2022
SELL
Open market or private sale
$22,648 $3.12 p/Share
7,259 Reduced 44.37%
9,102 Class A Common Stock
Sep 30 2022
BUY
Exercise of conversion of derivative security
-
16,361 Added 50.0%
16,361 Class A Common Stock
MED

Mark E. Dmytruk

Officer
Boston, MA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA